Haemostatic abnormalities in patients with liver disease

Assessing the Real-World Value of Hemophilia Care: How Suitable Are Patient-Centered Outcomes for Hospital-Level Comparisons?

International journal for quality in health care : journal of the International Society for Quality in Health Care·2026

Risk of thrombosis and bleeding following CAR T-cell therapy: Insights from the Dutch "Follow that CAR!" registry.

HemaSphere·2026

Impact of Delayed Heparin Bridging on Bleeding and Stroke After Left Ventricular Assist Device Implantation.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026

Neural network reveals platelet age from fluorescence microscopy images.

Platelets·2026

Etranacogene dezaparvovec in people with hemophilia B and without adeno-associated virus serotype 5 neutralizing antibodies: a 4-year subgroup analysis of the Health Outcomes with Padua Gene; Evaluation in Hemophilia B (HOPE-B) trial.

Research and practice in thrombosis and haemostasis·2026

Health care resources and costs associated with delivering gene therapy for hemophilia in clinical practice.

Research and practice in thrombosis and haemostasis·2026

The future of blood-based biomarkers in liver cancer.

Journal of hepatology·2026

Corticosteroid Therapy for Drug-induced Liver Injury: Mind the Gap!

Journal of hepatology·2026

Systemic therapy of biliary tract cancer: The road to personalised strategies.

Journal of hepatology·2026

Reproducibility of Biomarkers in MASLD: A Benchmark for Clinically Meaningful Change in Serially Measured Non-Invasive Tests.

Journal of hepatology·2026

The changing epidemiology of primary liver cancer in the 21st century.

Journal of hepatology·2026

Low-dose bevacizumab plus atezolizumab enhances transarterial chemoembolization in HCC via correcting vascular-immune niche dysfunction.

Journal of hepatology·2026

Living With Acquired Haemophilia: Patients' and Relatives' Experiences - A Single-Centre Study.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2026

Acute heparin-induced thrombocytopenia following aortic dissection repair with platelet count recovery and anti-platelet factor 4/heparin antibody seroreversion despite ongoing device-related heparin exposure.

Haematologica·2026

Rare inherited coagulation disorders and thrombosis.

Haematologica·2026

Coronary-Driven Cerebral Revascularization in Type 2a Takayasu Arteritis: A Rare Multisystem Collateral Phenotype.

Cureus·2026

Severe Secondary Haemophagocytic Lymphohistiocytosis Syndrome Due to Crimean-Congo Haemorrhagic Fever Virus: Thinking out of the Box.

European journal of case reports in internal medicine·2026

Comparison of the efficacy and safety of nafamostat mesylate and heparin in blood purification therapy for patients with severe acute pancreatitis: protocol for a randomized controlled trial.

Frontiers in medicine·2026

Related Experiment Videos

Haemostatic abnormalities in patients with liver disease

Related Concept Videos

Assessing the Real-World Value of Hemophilia Care: How Suitable Are Patient-Centered Outcomes for Hospital-Level Comparisons?

Risk of thrombosis and bleeding following CAR T-cell therapy: Insights from the Dutch "Follow that CAR!" registry.

Impact of Delayed Heparin Bridging on Bleeding and Stroke After Left Ventricular Assist Device Implantation.

Neural network reveals platelet age from fluorescence microscopy images.

Etranacogene dezaparvovec in people with hemophilia B and without adeno-associated virus serotype 5 neutralizing antibodies: a 4-year subgroup analysis of the Health Outcomes with Padua Gene; Evaluation in Hemophilia B (HOPE-B) trial.

Health care resources and costs associated with delivering gene therapy for hemophilia in clinical practice.

The future of blood-based biomarkers in liver cancer.

Corticosteroid Therapy for Drug-induced Liver Injury: Mind the Gap!

Systemic therapy of biliary tract cancer: The road to personalised strategies.

Reproducibility of Biomarkers in MASLD: A Benchmark for Clinically Meaningful Change in Serially Measured Non-Invasive Tests.

The changing epidemiology of primary liver cancer in the 21st century.

Low-dose bevacizumab plus atezolizumab enhances transarterial chemoembolization in HCC via correcting vascular-immune niche dysfunction.

Living With Acquired Haemophilia: Patients' and Relatives' Experiences - A Single-Centre Study.

Acute heparin-induced thrombocytopenia following aortic dissection repair with platelet count recovery and anti-platelet factor 4/heparin antibody seroreversion despite ongoing device-related heparin exposure.

Rare inherited coagulation disorders and thrombosis.

Coronary-Driven Cerebral Revascularization in Type 2a Takayasu Arteritis: A Rare Multisystem Collateral Phenotype.

Severe Secondary Haemophagocytic Lymphohistiocytosis Syndrome Due to Crimean-Congo Haemorrhagic Fever Virus: Thinking out of the Box.

Comparison of the efficacy and safety of nafamostat mesylate and heparin in blood purification therapy for patients with severe acute pancreatitis: protocol for a randomized controlled trial.

Related Experiment Videos

Haemostatic abnormalities in patients with liver disease

Related Concept Videos

Related Articles